Business Areas

1. Drug Safety:

• Pre-Clinical R & D:
• Functional Proteomics
• Predictive ADME / DMPK / Toxicology
• Predictive Metabolite Profiling
• Therapeutic Efficacy Analysis
   
• Clinical R & D:
• Target Validation
• Validation of Administration Routes
• Compliance Improvement
• Selection of Patient Risk Groups
• Adverse Event Monitoring
• Dose Optimization

2. Near-Patient Diagnostics – Point-of-Care:

• Drug Therapy Related Patient Self-Testing (Theranostics)
  
  Certain drugs may be linked to undesirable side effects that impact vital organs, e.g., heart, kidney, liver and/or immune system. Therefore, it may be desirable and advisable to monitor disease markers and vital analytes in order to optimize each drug’s therapeutic window and efficacy.
   
• Point-of-Care-Diagnostics (POC)
  
  In emergency medicine, the rapid availability of biochemical analytes and their concentration ranges may trigger a timely therapeutic approach and adequate allocation of patient management resources. POC has proven of particular interest within cardiology, endocrinology and infectious disease.